The startling findings raise the possibility that the medicines, originally developed to treat diabetes, could one day be ...

Users were quick to highlight one strikingly similar feature prolific among the A-listers gathered in Los Angeles - ...

The FDA’s recent approval of OZEMPIC highlights the expanding use of GLP-1 drugs beyond diabetes and weight management. Novo Nordisk’s blockbuster medication has gained another label expansion, now ...

The shortage of Ozempic and Wegovy has been declared over by the Food and Drug Administration, a change that suggests higher ...

Elon Musk wants to cut funding for scientific research, but the weight loss drugs he promoted also came from government funded basic science.

Ozempic, a diabetes drug turned weight-loss sensation, generated billions in annual sales, with U.S. pharmacies filling ...

People using semaglutide for diabetes or weight loss have also reported experiencing a reduced desire for alcohol.

New York, USA, Feb. 19, 2025 (GLOBE NEWSWIRE) -- Novo Nordisk's OZEMPIC Approval Heat Up the Chronic Kidney disease Therapeutic market | DelveInsight The FDA's recent approval of OZEMPIC ...

This will be a “pivotal year,” one expert says, for GLP-1 drugs, which are massively disrupting the benefits landscape.

Polar Capital Global Healthcare, which is co-managed by James Douglas, currently trades at a 3pc discount to its assets.